The US FDA has issued an Establishment Inspection Report (EIR) for Alkem Laboratories Ltd’s manufacturing facility located at Daman, India which was inspected from 26th August, 2019 to 30th August, 2019.
In response to the Form 483 issued by the US FDA containing two observations, the Company had submitted a detailed corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines. The inspection has now been closed by the US FDA.
The inspection conducted at the Company’s manufacturing facility located at Baddi, India from 19th August, 2019 to 21st August, 2019 where no Form 483 was received, an Establishment Inspection Report (EIR) has been received for the said facility located at Baddi, India and the inspection has now been closed by the US FDA.
Shares of Alkem Laboratories Ltd was last trading in BSE at Rs.2001.45 as compared to the previous close of Rs. 1989.85. The total number of shares traded during the day was 10277 in over 366 trades.
The stock hit an intraday high of Rs. 2005.9 and intraday low of 1990. The net turnover during the day was Rs. 20553233.
